it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done...

despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6..

lea ament, left, and tamara nunley talk about the care their team provided for helen and robert valenzuela at st. jude medical center in fullerton. (scott smeltzer / staff photographer).

...notify me of new posts via email..

harvard medical school: "cgrp: a new era for migraine treatment.".

international.

photos